The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Genomic complexity of multiple myeloma and its clinical implications
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Self-citationPredictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Herbst, R. S., Soria, J.-C., Kowanetz, M., Fine, G. D., Hamid, O., Gordon, M. S., Sosman, J. A., McDermott, D. F., Powderly, J. D., Gettinger, S. N., et al. (2014) · Nature · doi:10.1038/nature14011 · Cited by 5,231
Neoantigens in cancer immunotherapy
Schumacher, T. N., & Schreiber, R. D. (2015) · Science · doi:10.1126/science.aaa4971 · Cited by 4,783
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Self-citationGreaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
Self-citationInternational Staging System for Multiple Myeloma
Greipp, P. R., Miguel, J. S., Durie, B. G. M., Crowley, J. J., Barlogie, B., Bladé, J., Boccadoro, M., Child, J. A., Avet-Loiseau, H., Kyle, R. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.242 · Cited by 2,974
Palumbo, A., & Anderson, K. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011442 · Cited by 2,326
Palumbo, A., Avet-Loiseau, H., Oliva, S., Lokhorst, H. M., Goldschmidt, H., Rosinol, L., Richardson, P., Caltagirone, S., Lahuerta, J. J., Facon, T., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.2267 · Cited by 2,210
Raje, N., & Anderson, K. C. (2000) · Current Treatment Options in Oncology · doi:10.1007/s11864-000-0017-x · Cited by 2,163
Absolute quantification of somatic DNA alterations in human cancer
Carter, S. L., Cibulskis, K., Helman, E., McKenna, A., Shen, H., Zack, T., Laird, P. W., Onofrio, R. C., Winckler, W., Weir, B. A., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2203 · Cited by 2,053
Self-citationMutational Processes Molding the Genomes of 21 Breast Cancers
Nik-Zainal, S., Alexandrov, L. B., Wedge, D. C., Van Loo, P., Greenman, C. D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.024 · Cited by 1,909
Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
San Miguel, J. F., Schlag, R., Khuageva, N. K., Dimopoulos, M. A., Shpilberg, O., Kropff, M., Spicka, I., Petrucci, M. T., Palumbo, A., Samoilova, O. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801479 · Cited by 1,899
Pan-cancer patterns of somatic copy number alteration
Zack, T. I., Schumacher, S. E., Carter, S. L., Cherniack, A. D., Saksena, G., Tabak, B., Lawrence, M. S., Zhang, C.-Z., Wala, J., Mermel, C. H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2760 · Cited by 1,870
Self-citationRAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Poulikakos, P. I., Zhang, C., Bollag, G., Shokat, K. M., & Rosen, N. (2010) · Nature · doi:10.1038/nature08902 · Cited by 1,811
Initial genome sequencing and analysis of multiple myeloma
Chapman, M. A., Lawrence, M. S., Keats, J. J., Cibulskis, K., Sougnez, C., Schinzel, A. C., Harview, C. L., Brunet, J.-P., Ahmann, G. J., Adli, M., et al. (2011) · Nature · doi:10.1038/nature09837 · Cited by 1,433
Self-citationEvolution and impact of subclonal mutations in chronic lymphocytic leukemia
Landau, D. A., Carter, S. L., Stojanov, P., McKenna, A., Stevenson, K., Lawrence, M. S., Sougnez, C., Stewart, C., Sivachenko, A., Wang, L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.019 · Cited by 1,379
Self-citationThe molecular classification of multiple myeloma
Zhan, F., Huang, Y., Colla, S., Stewart, J. P., Hanamura, I., Gupta, S., Epstein, J., Yaccoby, S., Sawyer, J., Burington, B., et al. (2006) · Blood · doi:10.1182/blood-2005-11-013458 · Cited by 1,133
Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma
Swaminathan, B., Thorleifsson, G., Jöud, M., Ali, M., Johnsson, E., Ajore, R., Sulem, P., Halvarsson, B.-M., Eyjolfsson, G., Haraldsdottir, V., et al. (2015) · Nature Communications · doi:10.1038/ncomms8213 · Cited by 1,132
Landgren, O., Kyle, R. A., Pfeiffer, R. M., Katzmann, J. A., Caporaso, N. E., Hayes, R. B., Dispenzieri, A., Kumar, S., Clark, R. J., Baris, D., et al. (2009) · Blood · doi:10.1182/blood-2008-12-194241 · Cited by 1,127
Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
Lokhorst, H. M., Plesner, T., Laubach, J. P., Nahi, H., Gimsing, P., Hansson, M., Minnema, M. C., Lassen, U., Krejcik, J., Palumbo, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506348 · Cited by 1,117
Beroukhim, R., Getz, G., Nghiemphu, L., Barretina, J., Hsueh, T., Linhart, D., Vivanco, I., Lee, J. C., Huang, J. H., Alexander, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710052104 · Cited by 1,075
Self-citationLesokhin, A. M., Ansell, S. M., Armand, P., Scott, E. C., Halwani, A., Gutierrez, M., Millenson, M. M., Cohen, A. D., Schuster, S. J., Lebovic, D., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.9789 · Cited by 1,001
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
Lohr, J. G., Stojanov, P., Carter, S. L., Cruz-Gordillo, P., Lawrence, M. S., Auclair, D., Sougnez, C., Knoechel, B., Gould, J., Saksena, G., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.015 · Cited by 988
Self-citationPromiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983
Annunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.004 · Cited by 952
Avet-Loiseau, H., Attal, M., Moreau, P., Charbonnel, C., Garban, F., Hulin, C., Leyvraz, S., Michallet, M., Yakoub-Agha, I., Garderet, L., et al. (2007) · Blood · doi:10.1182/blood-2006-08-040410 · Cited by 911
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
Fonseca, R., Bergsagel, P. L., Drach, J., Shaughnessy, J., Gutierrez, N., Stewart, A. K., Morgan, G., Van Ness, B., Chesi, M., Minvielle, S., et al. (2009) · Leukemia · doi:10.1038/leu.2009.174 · Cited by 886
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Bolli, N., Avet-Loiseau, H., Wedge, D. C., Van Loo, P., Alexandrov, L. B., Martincorena, I., Dawson, K. J., Iorio, F., Nik-Zainal, S., Bignell, G. R., et al. (2014) · Nature Communications · doi:10.1038/ncomms3997 · Cited by 875
Lonial, S., Weiss, B. M., Usmani, S. Z., Singhal, S., Chari, A., Bahlis, N. J., Belch, A., Krishnan, A., Vescio, R. A., Mateos, M. V., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01120-4 · Cited by 854
Genetic variegation of clonal architecture and propagating cells in leukaemia
Anderson, K., Lutz, C., van Delft, F. W., Bateman, C. M., Guo, Y., Colman, S. M., Kempski, H., Moorman, A. V., Titley, I., Swansbury, J., et al. (2011) · Nature · doi:10.1038/nature09650 · Cited by 806
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
Cappellen, D., De Oliveira, C., Ricol, D., de Medina, S., Bourdin, J., Sastre-Garau, X., Chopin, D., Thiery, J. P., & Radvanyi, F. (1999) · Nature Genetics · doi:10.1038/12615 · Cited by 713
Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma
Bergsagel, P. L., Kuehl, W. M., Zhan, F., Sawyer, J., Barlogie, B., & Shaughnessy, J. (2005) · Blood · doi:10.1182/blood-2005-01-0034 · Cited by 698
Clinical and biologic implications of recurrent genomic aberrations in myeloma
Fonseca, R., Blood, E., Rue, M., Harrington, D., Oken, M. M., Kyle, R. A., Dewald, G. W., Van Ness, B., Van Wier, S. A., Henderson, K. J., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3017 · Cited by 660
Jänne, P. A., Shaw, A. T., Pereira, J. R., Jeannin, G., Vansteenkiste, J., Barrios, C., Franke, F. A., Grinsted, L., Zazulina, V., Smith, P., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70489-8 · Cited by 655
B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma
Carpenter, R. O., Evbuomwan, M. O., Pittaluga, S., Rose, J. J., Raffeld, M., Yang, S., Gress, R. E., Hakim, F. T., & Kochenderfer, J. N. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2422 · Cited by 653
ATM and ATR as therapeutic targets in cancer
Weber, A. M., & Ryan, A. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.001 · Cited by 635
Kumar, S. K., Mikhael, J. R., Buadi, F. K., Dingli, D., Dispenzieri, A., Fonseca, R., Gertz, M. A., Greipp, P. R., Hayman, S. R., Kyle, R. A., et al. (2009) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0603 · Cited by 628
Chesi, M., Nardini, E., Lim, R. S. C., Smith, K. D., Kuehl, W. M., & Bergsagel, P. L. (1998) · Blood · doi:10.1182/blood.v92.9.3025 · Cited by 572
Adjei, A. A., Cohen, R. B., Franklin, W., Morris, C., Wilson, D., Molina, J. R., Hanson, L. J., Gore, L., Chow, L., Leong, S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.4956 · Cited by 570
A monoclonal gammopathy precedes multiple myeloma in most patients
Weiss, B. M., Abadie, J., Verma, P., Howard, R. S., & Kuehl, W. M. (2009) · Blood · doi:10.1182/blood-2008-12-195008 · Cited by 569
Walker, B. A., Boyle, E. M., Wardell, C. P., Murison, A., Begum, D. B., Dahir, N. M., Proszek, P. Z., Johnson, D. C., Kaiser, M. F., Melchor, L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.1503 · Cited by 567
Kim, J. H., Kim, J. W., Kim, Y. N., Kim, H. I., Kim, J. Y., Kwon, G. Y., Kim, K., & Jang, H. R. (2015) · Case Reports in Nephrology and Dialysis · doi:10.1159/000439267 · Cited by 538
Gavine, P. R., Mooney, L., Kilgour, E., Thomas, A. P., Al-Kadhimi, K., Beck, S., Rooney, C., Coleman, T., Baker, D., Mellor, M. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3034 · Cited by 501
Mikhael, J. R., Dingli, D., Roy, V., Reeder, C. B., Buadi, F. K., Hayman, S. R., Dispenzieri, A., Fonseca, R., Sher, T., Kyle, R. A., et al. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.01.019 · Cited by 500
Hanamura, I., Stewart, J. P., Huang, Y., Zhan, F., Santra, M., Sawyer, J. R., Hollmig, K., Zangarri, M., Pineda-Roman, M., van Rhee, F., et al. (2006) · Blood · doi:10.1182/blood-2006-03-009910 · Cited by 479
Carrasco, D. R., Tonon, G., Huang, Y., Zhang, Y., Sinha, R., Feng, B., Stewart, J. P., Zhan, F., Khatry, D., Protopopova, M., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.019 · Cited by 425
Avet-Loiseau, H., Leleu, X., Roussel, M., Moreau, P., Guerin-Charbonnel, C., Caillot, D., Marit, G., Benboubker, L., Voillat, L., Mathiot, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.3945 · Cited by 424
A single subunit, Dis3, is essentially responsible for yeast exosome core activity
Dziembowski, A., Lorentzen, E., Conti, E., & Séraphin, B. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1184 · Cited by 420
Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair
Haradhvala, N. J., Polak, P., Stojanov, P., Covington, K. R., Shinbrot, E., Hess, J. M., Rheinbay, E., Kim, J., Maruvka, Y. E., Braunstein, L. Z., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.050 · Cited by 411
Self-citationMMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites
Pei, H., Zhang, L., Luo, K., Qin, Y., Chesi, M., Fei, F., Bergsagel, P. L., Wang, L., You, Z., & Lou, Z. (2011) · Nature · doi:10.1038/nature09658 · Cited by 408
Tricot, G., Barlogie, B., Jagannath, S., Bracy, D., Mattox, S., Vesole, D., Naucke, S., & Sawyer, Jr. (1995) · Blood · doi:10.1182/blood.v86.11.4250.bloodjournal86114250 · Cited by 395
Hypodiploidy is a major prognostic factor in multiple myeloma
Smadja, N. V., Bastard, C., Brigaudeau, C., Leroux, D., & Fruchart, C. (2001) · Blood · doi:10.1182/blood.v98.7.2229 · Cited by 390
Keats, J. J., Reiman, T., Maxwell, C. A., Taylor, B. J., Larratt, L. M., Mant, M. J., Belch, A. R., & Pilarski, L. M. (2003) · Blood · doi:10.1182/blood-2002-06-1675 · Cited by 382
Hurt, E. M., Wiestner, A., Rosenwald, A., Shaffer, A. L., Campo, E., Grogan, T., Bergsagel, P. L., Kuehl, W. M., & Staudt, L. M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00019-4 · Cited by 377
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma
Pasqualucci, L., Compagno, M., Houldsworth, J., Monti, S., Grunn, A., Nandula, S. V., Aster, J. C., Murty, V. V., Shipp, M. A., & Dalla-Favera, R. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052204 · Cited by 370
A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value
Walker, B. A., Leone, P. E., Chiecchio, L., Dickens, N. J., Jenner, M. W., Boyd, K. D., Johnson, D. C., Gonzalez, D., Dagrada, G. P., Protheroe, R. K. M., et al. (2010) · Blood · doi:10.1182/blood-2010-04-279596 · Cited by 365
Martinez-Garcia, E., Popovic, R., Min, D.-J., Sweet, S. M. M., Thomas, P. M., Zamdborg, L., Heffner, A., Will, C., Lamy, L., Staudt, L. M., et al. (2011) · Blood · doi:10.1182/blood-2010-07-298349 · Cited by 360
Genetic aberrations and survival in plasma cell leukemia
Tiedemann, R. E., Gonzalez-Paz, N., Kyle, R. A., Santana-Davila, R., Price-Troska, T., Van Wier, S. A., Chng, W. J., Ketterling, R. P., Gertz, M. A., Henderson, K., et al. (2008) · Leukemia · doi:10.1038/leu.2008.4 · Cited by 349
Genomic abnormalities in monoclonal gammopathy of undetermined significance
Fonseca, R., Bailey, R. J., Ahmann, G. J., Rajkumar, S. V., Hoyer, J. D., Lust, J. A., Kyle, R. A., Gertz, M. A., Greipp, P. R., & Dewald, G. W. (2002) · Blood · doi:10.1182/blood.v100.4.1417.h81602001417_1417_1424 · Cited by 348
FGFR Genetic Alterations Predict for Sensitivity to NVP-BGJ398, a Selective Pan-FGFR Inhibitor
Guagnano, V., Kauffmann, A., Wöhrle, S., Stamm, C., Ito, M., Barys, L., Pornon, A., Yao, Y., Li, F., Zhang, Y., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0210 · Cited by 347
Drach, J., Ackermann, J., Fritz, E., Krömer, E., Schuster, R., Gisslinger, H., DeSantis, M., Zojer, N., Fiegl, M., Roka, S., et al. (1998) · Blood · doi:10.1182/blood.v92.3.802 · Cited by 325
Walker, B. A., Wardell, C. P., Murison, A., Boyle, E. M., Begum, D. B., Dahir, N. M., Proszek, P. Z., Melchor, L., Pawlyn, C., Kaiser, M. F., et al. (2015) · Nature Communications · doi:10.1038/ncomms7997 · Cited by 313
Lonial, S., Vij, R., Harousseau, J.-L., Facon, T., Moreau, P., Mazumder, A., Kaufman, J. L., Leleu, X., Tsao, L. C., Westland, C., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.2649 · Cited by 296
The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma
Fonseca, R., Debes-Marun, C. S., Picken, E. B., Dewald, G. W., Bryant, S. C., Winkler, J. M., Blood, E., Oken, M. M., Santana-Dávila, R., González-Paz, N., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0493 · Cited by 296
Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors
Avet-Loiseau, H., Gerson, F., Magrangeas, F., Minvielle, S., Harousseau, J.-L., & Bataille, R. (2001) · Blood · doi:10.1182/blood.v98.10.3082 · Cited by 289
Walker, B. A., Wardell, C. P., Melchor, L., Brioli, A., Johnson, D. C., Kaiser, M. F., Mirabella, F., Lopez-Corral, L., Humphray, S., Murray, L., et al. (2014) · Leukemia · doi:10.1038/leu.2013.199 · Cited by 283
Chesi, M., Bergsagel, P., Brents, L., Smith, C., Gerhard, D., & Kuehl, W. (1996) · Blood · doi:10.1182/blood.v88.2.674.bloodjournal882674 · Cited by 277
Prognostic Significance of Copy-Number Alterations in Multiple Myeloma
Avet-Loiseau, H., Li, C., Magrangeas, F., Gouraud, W., Charbonnel, C., Harousseau, J.-L., Attal, M., Marit, G., Mathiot, C., Facon, T., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.6136 · Cited by 276
Clinical responses with T lymphocytes targeting malignancy-associated κ light chains
Ramos, C. A., Savoldo, B., Torrano, V., Ballard, B., Zhang, H., Dakhova, O., Liu, E., Carrum, G., Kamble, R. T., Gee, A. P., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86000 · Cited by 276
Affer, M., Chesi, M., Chen, W. D., Keats, J. J., Demchenko, Y. N., Tamizhmani, K., Garbitt, V. M., Riggs, D. L., Brents, L. A., Roschke, A. V., et al. (2014) · Leukemia · doi:10.1038/leu.2014.70 · Cited by 268
Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling
Chng, W. J., Kumar, S., VanWier, S., Ahmann, G., Price-Troska, T., Henderson, K., Chung, T.-H., Kim, S., Mulligan, G., Bryant, B., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4046 · Cited by 259
The exosome: a multipurpose RNA-decay machine
Schmid, M., & Jensen, T. H. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.07.003 · Cited by 257
Targeting the BRAF V600E Mutation in Multiple Myeloma
Andrulis, M., Lehners, N., Capper, D., Penzel, R., Heining, C., Huellein, J., Zenz, T., von Deimling, A., Schirmacher, P., Ho, A. D., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0014 · Cited by 234
Melchor, L., Brioli, A., Wardell, C. P., Murison, A., Potter, N. E., Kaiser, M. F., Fryer, R. A., Johnson, D. C., Begum, D. B., Hulkki Wilson, S., et al. (2014) · Leukemia · doi:10.1038/leu.2014.13 · Cited by 233
Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas
Tam, W., Gomez, M., Chadburn, A., Lee, J. W., Chan, W. C., & Knowles, D. M. (2006) · Blood · doi:10.1182/blood-2005-09-3778 · Cited by 230
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma
Debes-Marun, C. S., Dewald, G. W., Bryant, S., Picken, E., Santana-Dávila, R., González-Paz, N., Winkler, J. M., Kyle, R. A., Gertz, M. A., Witzig, T. E., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402797 · Cited by 227
Baughn, L. B., Di Liberto, M., Wu, K., Toogood, P. L., Louie, T., Gottschalk, R., Niesvizky, R., Cho, H., Ely, S., Moore, M. A. S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1098 · Cited by 225
Shaughnessy, J., Gabrea, A., Qi, Y., Brents, L., Zhan, F., Tian, E., Sawyer, J., Barlogie, B., Bergsagel, P. L., & Kuehl, M. (2001) · Blood · doi:10.1182/blood.v98.1.217 · Cited by 223
Sawyer, J. R., Tricot, G., Mattox, S., Jagannath, S., & Barlogie, B. (1998) · Blood · doi:10.1182/blood.v91.5.1732 · Cited by 217
Landgren, O., Graubard, B. I., Katzmann, J. A., Kyle, R. A., Ahmadizadeh, I., Clark, R., Kumar, S. K., Dispenzieri, A., Greenberg, A. J., Therneau, T. M., et al. (2014) · Leukemia · doi:10.1038/leu.2014.34 · Cited by 208
Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma
González, D., van der Burg, M., García-Sanz, R., Fenton, J. A., Langerak, A. W., González, M., van Dongen, J. J. M., San Miguel, J. F., & Morgan, G. J. (2007) · Blood · doi:10.1182/blood-2007-02-069625 · Cited by 208
Jakubowiak, A. J., Benson, D. M., Bensinger, W., Siegel, D. S. D., Zimmerman, T. M., Mohrbacher, A., Richardson, P. G., Afar, D. E. H., Singhal, A. K., & Anderson, K. C. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.7069 · Cited by 205
Avet‐Loiseau, H., Facon, T. T. F., Daviet, A., Godon, C., Rapp, M.-J., Harousseau, J., Grosbois, B., & Bataille, R. (1999) · PubMed · Cited by 194
Chang, H., Sloan, S., Li, D., Zhuang, L., Yi, Q., Chen, C. I., Reece, D., Chun, K., & Keith Stewart, A. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04867.x · Cited by 193
Avet-Loiseau, H., Li, J.-Y., Morineau, N., Facon, T., Brigaudeau, C., Harousseau, J.-L., Grosbois, B., & Bataille, R. (1999) · Blood · doi:10.1182/blood.v94.8.2583.420a05_2583_2589 · Cited by 192
Walker, B. A., Leone, P. E., Jenner, M. W., Li, C., Gonzalez, D., Johnson, D. C., Ross, F. M., Davies, F. E., & Morgan, G. J. (2006) · Blood · doi:10.1182/blood-2006-02-005496 · Cited by 187
Santra, M., Zhan, F., Tian, E., Barlogie, B., & Shaughnessy, J. (2003) · Blood · doi:10.1182/blood-2002-09-2801 · Cited by 184
Walker, B. A., Wardell, C. P., Brioli, A., Boyle, E., Kaiser, M. F., Begum, D. B., Dahir, N. B., Johnson, D. C., Ross, F. M., Davies, F. E., et al. (2014) · Blood Cancer Journal · doi:10.1038/bcj.2014.13 · Cited by 181
Keats, J. J., Maxwell, C. A., Taylor, B. J., Hendzel, M. J., Chesi, M., Bergsagel, P. L., Larratt, L. M., Mant, M. J., Reiman, T., Belch, A. R., et al. (2005) · Blood · doi:10.1182/blood-2004-09-3704 · Cited by 181
Boyd, K. D., Ross, F. M., Walker, B. A., Wardell, C. P., Tapper, W. J., Chiecchio, L., Dagrada, G., Konn, Z. J., Gregory, W. M., Jackson, G. H., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1791 · Cited by 174
Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases
Smadja, N.-V., Fruchart, C., Isnard, F., Louvet, C., Dutel, J.-L., Cheron, N., Grange, M.-J., Monconduit, M., & Bastard, C. (1998) · Leukemia · doi:10.1038/sj.leu.2401041 · Cited by 168
Walker, B. A., Wardell, C. P., Johnson, D. C., Kaiser, M. F., Begum, D. B., Dahir, N. B., Ross, F. M., Davies, F. E., Gonzalez, D., & Morgan, G. J. (2013) · Blood · doi:10.1182/blood-2012-12-471888 · Cited by 166
Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk
Chubb, D., Weinhold, N., Broderick, P., Chen, B., Johnson, D. C., Försti, A., Vijayakrishnan, J., Migliorini, G., Dobbins, S. E., Holroyd, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2733 · Cited by 164
Clonal evolution in hematological malignancies and therapeutic implications
Landau, D. A., Carter, S. L., Getz, G., & Wu, C. J. (2014) · Leukemia · doi:10.1038/leu.2013.248 · Cited by 164
Self-citationCommon variation at 3p22.1 and 7p15.3 influences multiple myeloma risk
Broderick, P., Chubb, D., Johnson, D. C., Weinhold, N., Försti, A., Lloyd, A., Olver, B., Ma, Y. P., Dobbins, S. E., Walker, B. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.993 · Cited by 163
Chiecchio, L., Protheroe, R. K. M., Ibrahim, A. H., Cheung, K. L., Rudduck, C., Dagrada, G. P., Cabanas, E. D., Parker, T., Nightingale, M., Wechalekar, A., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404304 · Cited by 161
Shaughnessy, J. (2005) · Hematology · doi:10.1080/10245330512331390140 · Cited by 159
Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma
Lodé, L., Eveillard, M., Trichet, V., Soussi, T., Wuillème, S., Richebourg, S., Magrangeas, F., Ifrah, N., Campion, L., Traullé, C., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.023697 · Cited by 152
Fonseca, R., Oken, M., Harrington, D. P., Bailey, R., Wier, S. V., Henderson, K. J., Kay, N. E., Ness, B. V., Greipp, P., & Dewald, G. (2001) · Leukemia · doi:10.1038/sj.leu.2402125 · Cited by 140
Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?
Avet‐Loiseau, H., Malard, F., Campion, L., Magrangeas, F., Sebban, C., Lioure, B., Decaux, O., Lamy, T., Legros, L., Fuzibet, J., et al. (2010) · Blood · doi:10.1182/blood-2010-07-295105 · Cited by 130
A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS
Chng, W. J., Wier, S. A. V., Ahmann, G. J., Winkler, J. M., Jalal, S. M., Bergsagel, P. L., Chesi, M., Trendle, M. C., Oken, M. M., Blood, E., et al. (2005) · Blood · doi:10.1182/blood-2005-02-0761 · Cited by 128
The Genetic Architecture of Multiple Myeloma
Prideaux, S. M., O’Brien, E. C., & Chevassut, T. J. T. (2014) · Advances in Hematology · doi:10.1155/2014/864058 · Cited by 125
Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?
Chrétien, M., Corre, J., Lauwers‐Cancès, V., Magrangeas, F., Cleynen, A., Yon, E., Hulin, C., Leleu, X. P., Orsini‐Piocelle, F., Blade, J., et al. (2015) · Blood · doi:10.1182/blood-2015-06-650242 · Cited by 121
Shi, L., Wang, S., Zangari, M., Xu, H., Cao, T. M., Xu, C., Wu, Y., Xiao, F., Liu, Y., Yang, Y., et al. (2010) · Oncotarget · doi:10.18632/oncotarget.105 · Cited by 115
The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma
Weinhold, N., Johnson, D. C., Chubb, D., Chen, B., Försti, A., Hosking, F. J., Broderick, P., Ma, Y. P., Dobbins, S. E., Hose, D., et al. (2013) · Nature Genetics · doi:10.1038/ng.2583 · Cited by 114
Smadja, N., Leroux, D., Soulier, J., Dumont, S., Arnould, C., Taviaux, S. A., Taillemite, J. L., & Bastard, C. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10275 · Cited by 105
Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13
Avet‐Loiseau, H., Daviet, A., Saunier, S., & Bataille, R. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02488.x · Cited by 104
Ross, F. M., Chiecchio, L., Dagrada, G. P., Protheroe, R. K. M., Stockley, D. M., Harrison, C. J., Cross, N. C. P., Szubert, A. J., Drayson, M. T., Morgan, G. J., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.016329 · Cited by 101
Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
Solvason, N. W., Wu, W. W., Kabra, N. H., Wu, X., Lees, E. M., & Howard, M. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.2.407 · Cited by 98
Hanamura, I., Iida, S., Akano, Y., Hayami, Y., Kato, M., Miura, K., Harada, S., Banno, S., Wakita, A., Kiyoi, H., et al. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01142.x · Cited by 97
Formation of a hyperdiploid karyotype in childhood acute lymphoblastic leukemia [see comments]
Onodera, N., McCabe, N., & Rubin, C. (1992) · Blood · doi:10.1182/blood.v80.1.203.203 · Cited by 90
Familial risks and temporal incidence trends of multiple myeloma
Altieri, A., Chen, B., Bermejo, J. L., Castro, F. A., & Hemminki, K. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.11.033 · Cited by 89
Kaufmann, H., Ackermann, J., Baldia, C., Nösslinger, T., Wieser, R., Seidl, S., Sagaster, V., Gisslinger, H., Jaeger, U., Pfeilstöcker, M., et al. (2004) · Leukemia · doi:10.1038/sj.leu.2403518 · Cited by 84
Abdel-Wahab, O. I., Klimek, V. M., Gaskell, A. A., Viale, A. J., Cheng, D. T., Kim, E. H., Rampal, R. K., Bluth, M. J., Harding, J. J., Callahan, M. K., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-1038 · Cited by 84
Darwinian evolution and tiding clones in multiple myeloma
Bahlis, N. J. (2012) · Blood · doi:10.1182/blood-2012-06-430645 · Cited by 82
Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma
Ross, F. M., Ibrahim, A., Vilain-Holmes, A., Winfield, M., Chiecchio, L., Protheroe, R. K. M., Strike, P. W., Gunasekera, J. L., Jones, A. V., Harrison, C. J., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403857 · Cited by 81
Chang, H., Qi, X., Jiang, A., Xu, W., Young, T., & Reece, D. E. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.107 · Cited by 81
Pawlyn, C., Melchor, L., Murison, A., Wardell, C. P., Brioli, A., Boyle, E. M., Kaiser, M., Walker, B. A., Begum, D. B., Dahir, N. B., et al. (2014) · Blood · doi:10.1182/blood-2014-07-584268 · Cited by 74
The molecular spectrum and clinical impact of DIS 3 mutations in multiple myeloma
Weißbach, S., Langer, C., Puppe, B., Nedeva, T., Bach, E., Kull, M., Bargou, R. C., Einsele, H., Rosenwald, A., Knop, S. T., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.13256 · Cited by 69
Sawyer, J. R., Tian, E., Heuck, C. J., Epstein, J., Johann, D. J., Swanson, C. M., Lukacs, J. L., Johnson, M., Binz, R. L., Boast, A., et al. (2014) · Blood · doi:10.1182/blood-2013-12-546077 · Cited by 50
Fournier, A., Leer, A. M., Lefebvre, C., Duley, S., Barki‐Celli, L., Ribeyron, J., Kassambara, A., Hamaidia, S., Granjon, A., Gressin, R., et al. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000067 · Cited by 46
Ziv, E., Dean, E. W., Hu, D., Martino, A., Serie, D., Curtin, K., Campa, D., Aftab, B. T., Bracci, P. M., Buda, G., et al. (2015) · Nature Communications · doi:10.1038/ncomms8539 · Cited by 45
Tanguay, D. A., & Chiles, T. C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.2.539 · Cited by 44
Weinhold, N., Kirn, D., Seckinger, A., Hielscher, T., Granzow, M., Bertsch, U., Egerer, G., Salwender, H. J., Blau, I. W., Weisel, K. C., et al. (2015) · Haematologica · doi:10.3324/haematol.2015.136929 · Cited by 44
Inherited genetic susceptibility to monoclonal gammopathy of unknown significance
Weinhold, N., Johnson, D. C., Rawstron, A. C., Försti, A., Doughty, C., Vijayakrishnan, J., Broderick, P., Dahir, N. B., Begum, D. B., Hosking, F. J., et al. (2014) · Blood · doi:10.1182/blood-2013-10-532283 · Cited by 43
Chang, H., Jiang, A., Qi, C. X. Y., Trieu, Y., Chen, C. I., & Reece, D. E. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.524325 · Cited by 39
Genetic factors influencing the risk of multiple myeloma bone disease
Johnson, D. C., Weinhold, N., Mitchell, J. S., Chen, B., Stephens, O., Försti, A., Nickel, J., Kaiser, M., Gregory, W. M., Cairns, D. A., et al. (2015) · Leukemia · doi:10.1038/leu.2015.342 · Cited by 11
Cited by
Campo, E., Jaffe, E. S., Cook, J. R., Quintanilla-Martinez, L., Swerdlow, S. H., Anderson, K. C., Brousset, P., Cerroni, L., de Leval, L., Dirnhofer, S., et al. (2022) · Blood · doi:10.1182/blood.2022015851 · Cited by 1,608
Self-citationCrosby, D., Bhatia, S., Brindle, K. M., Coussens, L. M., Dive, C., Emberton, M., Esener, S., Fitzgerald, R. C., Gambhir, S. S., Kuhn, P., et al. (2022) · Science · doi:10.1126/science.aay9040 · Cited by 1,379
Kumar, S. K., Rajkumar, V., Kyle, R. A., van Duin, M., Sonneveld, P., Mateos, M.-V., Gay, F., & Anderson, K. C. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.46 · Cited by 1,177
Context is everything: aneuploidy in cancer
Ben-David, U., & Amon, A. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-019-0171-x · Cited by 665
Driver Fusions and Their Implications in the Development and Treatment of Human Cancers
Gao, Q., Liang, W.-W., Foltz, S. M., Mutharasu, G., Jayasinghe, R. G., Cao, S., Liao, W.-W., Reynolds, S. M., Wyczalkowski, M. A., Yao, L., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.050 · Cited by 604
Self-citation
Metadata
- Authors
- Manier, S., Salem, K. Z., Park, J., Landau, D. A., Getz, G., & Ghobrial, I. M.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2016-08-17
- Volume
- 14
- Issue
- 2
- Pages
- 100-113
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W2511571730
- Cited by
- 560
- References
- 133
- FWCI
- 8.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.